PUBLIC COMPANY
saveLongboard Pharmaceuticals Inc
updated 13d ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
- phase3A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
- phase3A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
- phase2Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
- —Intermediate-Size Expanded Access Protocol (EAP) for LP352
- phase2Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that